Read Time:14 Second

A phase 2 clinical trial using a new technology show it is possible to induce immune tolerance to gluten in individuals with celiac disease. After treatment with the technology, the patients were able to eat gluten with a substantial reduction in inflammation.

Source: New treatment may reverse celiac disease

Average Rating

5 Star
0%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%

Leave a Reply

Discover more from CLINICALNEWS.ORG

Subscribe now to keep reading and get access to the full archive.

Continue reading